From Covishield to Novovax: Who will make how many vaccine vials to reach India'...
As India reiterates its vaccine policy with an ambitious target of 200 crore doses by year-end, a look at how many vials will be likely made available by each of these seven manufacturers in the Augus...
Divya writes about gender, philanthropy, startup and workplace trends, and business from the lens of its impact on people. She is keen to find interesting stories and new ways of telling them. A journ
Manu Balachandran is a writer for Forbes India, based in Bengaluru. At Forbes India, Manu writes on automobiles, aviation, pharmaceuticals, banking, infrastructure, economy and long profiles among man
